AWP Litigation: Three More Companies Ink Deals With DoJ; Roxane Sets A Record
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
You may also be interested in...
The settlement resolves claims McKesson inflated the average wholesale price of more than 1,400 brand drugs.
Wholesale drug distributor McKesson settles charges that it reported inflated average wholesale prices (AWPs) for a large number of branded prescription pharmaceuticals, leading to extensive overpayments by the Medicaid program.
HHS and the Department of Justice note actions taken last year in their Health Care Fraud and Abuse Control Program Annual Report for fiscal year 2011; enforcement actions net a record sum.